Lee, T.-H.; Chen, H.-L.; Chang, H.-M.; Wu, C.-M.; Wu, K.-L.; Kuo, C.-Y.; Wei, P.-J.; Chen, C.-L.; Liu, H.-L.; Hung, J.-Y.;
et al. Impact of Smoking Status in Combination Treatment with EGFR Tyrosine Kinase Inhibitors and Anti-Angiogenic Agents in Advanced Non-Small Cell Lung Cancer Harboring Susceptible EGFR Mutations: Systematic Review and Meta-Analysis. J. Clin. Med. 2022, 11, 3366.
https://doi.org/10.3390/jcm11123366
AMA Style
Lee T-H, Chen H-L, Chang H-M, Wu C-M, Wu K-L, Kuo C-Y, Wei P-J, Chen C-L, Liu H-L, Hung J-Y,
et al. Impact of Smoking Status in Combination Treatment with EGFR Tyrosine Kinase Inhibitors and Anti-Angiogenic Agents in Advanced Non-Small Cell Lung Cancer Harboring Susceptible EGFR Mutations: Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2022; 11(12):3366.
https://doi.org/10.3390/jcm11123366
Chicago/Turabian Style
Lee, Tai-Huang, Hsiao-Ling Chen, Hsiu-Mei Chang, Chiou-Mei Wu, Kuan-Li Wu, Chia-Yu Kuo, Po-Ju Wei, Chin-Ling Chen, Hui-Lin Liu, Jen-Yu Hung,
and et al. 2022. "Impact of Smoking Status in Combination Treatment with EGFR Tyrosine Kinase Inhibitors and Anti-Angiogenic Agents in Advanced Non-Small Cell Lung Cancer Harboring Susceptible EGFR Mutations: Systematic Review and Meta-Analysis" Journal of Clinical Medicine 11, no. 12: 3366.
https://doi.org/10.3390/jcm11123366
APA Style
Lee, T.-H., Chen, H.-L., Chang, H.-M., Wu, C.-M., Wu, K.-L., Kuo, C.-Y., Wei, P.-J., Chen, C.-L., Liu, H.-L., Hung, J.-Y., Yang, C.-J., & Chong, I.-W.
(2022). Impact of Smoking Status in Combination Treatment with EGFR Tyrosine Kinase Inhibitors and Anti-Angiogenic Agents in Advanced Non-Small Cell Lung Cancer Harboring Susceptible EGFR Mutations: Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 11(12), 3366.
https://doi.org/10.3390/jcm11123366
